ATE525072T1 - Pyrazole zur behandlung von adipositas und anderen zns-erkrankungen - Google Patents
Pyrazole zur behandlung von adipositas und anderen zns-erkrankungenInfo
- Publication number
- ATE525072T1 ATE525072T1 AT07749543T AT07749543T ATE525072T1 AT E525072 T1 ATE525072 T1 AT E525072T1 AT 07749543 T AT07749543 T AT 07749543T AT 07749543 T AT07749543 T AT 07749543T AT E525072 T1 ATE525072 T1 AT E525072T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrazoles
- obesity
- treatment
- cns diseases
- cns
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 150000003217 pyrazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77176806P | 2006-02-09 | 2006-02-09 | |
| PCT/US2007/002547 WO2007094962A2 (en) | 2006-02-09 | 2007-01-30 | Pyrazoles for the treatment of obesity and other cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE525072T1 true ATE525072T1 (de) | 2011-10-15 |
Family
ID=38371978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07749543T ATE525072T1 (de) | 2006-02-09 | 2007-01-30 | Pyrazole zur behandlung von adipositas und anderen zns-erkrankungen |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7897634B2 (de) |
| EP (1) | EP1988777B1 (de) |
| JP (1) | JP5207983B2 (de) |
| AR (1) | AR059428A1 (de) |
| AT (1) | ATE525072T1 (de) |
| CA (1) | CA2641441A1 (de) |
| DK (1) | DK1988777T3 (de) |
| TW (1) | TWI386403B (de) |
| WO (1) | WO2007094962A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008019302A1 (en) * | 2006-08-04 | 2008-02-14 | Decode Genetics Ehf | Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| US20100113776A1 (en) * | 2006-12-14 | 2010-05-06 | Taisho Pharmaceutical Co.,Ltd. | Pyrazole derivative |
| EA019031B1 (ru) | 2007-05-03 | 2013-12-30 | Сефалон, Инк. | Способ получения 6-{4-[3-((r)-2-метилпирролидин-1-ил)пропокси]фенил}-2н-пиридазин-3-она и его фармацевтически приемлемой соли |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EP2221298B1 (de) * | 2007-11-13 | 2013-11-06 | Taisho Pharmaceutical Co., Ltd | Phenylparazolderivate |
| JP5740838B2 (ja) * | 2009-05-12 | 2015-07-01 | 大正製薬株式会社 | フェニルピラゾール誘導体 |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| RU2618228C2 (ru) | 2011-12-08 | 2017-05-03 | Тайсо Фармасьютикал Ко., Лтд. | Производное фенилпиррола |
| EP2799436A4 (de) | 2011-12-27 | 2015-07-01 | Taisho Pharmaceutical Co Ltd | Phenyltriazolderivat |
| PL3828173T3 (pl) | 2014-03-07 | 2022-12-19 | Biocryst Pharmaceuticals, Inc. | Podstawiane pirazole jako inhibitory ludzkiej kalikreiny osoczowej |
| US11509102B1 (en) | 2017-05-07 | 2022-11-22 | Jeffrey P. Baldwin | Powered wall plate with plug prongs |
| US11189975B1 (en) | 2017-05-07 | 2021-11-30 | Jeffrey P. Baldwin | Powered wall plate |
| US11778302B1 (en) | 2019-04-23 | 2023-10-03 | Titan3 Technology LLC | Electrical wall plate with movably positionable camera |
| US11489280B1 (en) | 2019-06-04 | 2022-11-01 | Jeffrey P. Baldwin | Powered wall plate with keyed interface |
| US12335593B2 (en) | 2020-12-30 | 2025-06-17 | Titan3 Technology LLC | Electrical receptacle with built-in camera |
| US11489323B1 (en) | 2021-02-05 | 2022-11-01 | Jeffrey P. Baldwin | Powered wall plate with adjustable plug prongs |
| US12327956B1 (en) | 2022-02-01 | 2025-06-10 | Titan3 Technology LLC | Two-part powered electrical wall plate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3940418A (en) | 1972-04-07 | 1976-02-24 | G. D. Searle & Co. | Esters and amides of 4,5-dihydrobenz[g]indazole-3-carboxylic acids and related compounds |
| FR2711140B1 (fr) * | 1993-10-12 | 1996-01-05 | Sanofi Sa | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. |
| IL148718A0 (en) * | 1999-09-17 | 2002-09-12 | Abbott Gmbh & Co Kg | Pyrazolopyrimidines as therapeutic agents |
| BR0212611A (pt) * | 2001-09-19 | 2004-08-17 | Pharmacia Corp | Compostos de pirazolila substituìdos para o tratamento da inflamação |
| US7202257B2 (en) * | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| WO2005016877A2 (en) * | 2003-08-07 | 2005-02-24 | Merck & Co., Inc. | Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| US7517900B2 (en) | 2003-10-10 | 2009-04-14 | Bristol-Myers Squibb Company | Pyrazole derivatives as cannabinoid receptor modulators |
| ATE517885T1 (de) * | 2004-04-30 | 2011-08-15 | Bayer Healthcare Llc | Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs |
| JP4857267B2 (ja) * | 2004-06-30 | 2012-01-18 | アサーシス， インク． | 認識障害、睡眠障害、肥満及びその他のｃｎｓ障害を治療するためのヒスタミン３受容体インヒビターとなる非イミダゾール第三級アミン |
| WO2007073405A1 (en) * | 2005-12-21 | 2007-06-28 | Decode Genetics Ehf | N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| WO2008019302A1 (en) * | 2006-08-04 | 2008-02-14 | Decode Genetics Ehf | Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
-
2007
- 2007-01-30 DK DK07749543.0T patent/DK1988777T3/da active
- 2007-01-30 CA CA002641441A patent/CA2641441A1/en not_active Abandoned
- 2007-01-30 EP EP07749543A patent/EP1988777B1/de not_active Not-in-force
- 2007-01-30 WO PCT/US2007/002547 patent/WO2007094962A2/en not_active Ceased
- 2007-01-30 JP JP2008554271A patent/JP5207983B2/ja not_active Expired - Fee Related
- 2007-01-30 US US11/699,662 patent/US7897634B2/en not_active Expired - Fee Related
- 2007-01-30 AT AT07749543T patent/ATE525072T1/de not_active IP Right Cessation
- 2007-02-09 TW TW096104902A patent/TWI386403B/zh not_active IP Right Cessation
- 2007-02-09 AR ARP070100559A patent/AR059428A1/es unknown
-
2011
- 2011-01-13 US US13/006,161 patent/US7981896B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1988777T3 (da) | 2012-01-16 |
| JP5207983B2 (ja) | 2013-06-12 |
| US7897634B2 (en) | 2011-03-01 |
| US7981896B2 (en) | 2011-07-19 |
| US20110112088A1 (en) | 2011-05-12 |
| WO2007094962A2 (en) | 2007-08-23 |
| TWI386403B (zh) | 2013-02-21 |
| EP1988777B1 (de) | 2011-09-21 |
| US20070197526A1 (en) | 2007-08-23 |
| JP2009526054A (ja) | 2009-07-16 |
| TW200745092A (en) | 2007-12-16 |
| AR059428A1 (es) | 2008-04-09 |
| EP1988777A2 (de) | 2008-11-12 |
| WO2007094962A3 (en) | 2008-01-31 |
| CA2641441A1 (en) | 2007-08-23 |
| EP1988777A4 (de) | 2010-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE525072T1 (de) | Pyrazole zur behandlung von adipositas und anderen zns-erkrankungen | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| IL193473A0 (en) | Amide derivatives and their application for the treatment of g protein related diseases | |
| ATE512948T1 (de) | Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen | |
| EP2249752C0 (de) | Vorrichtung zur behandlung von adipositas | |
| EP1981526A4 (de) | Adiponectin zur behandlung verschiedener erkrankungen | |
| EP2300035A4 (de) | Gemischte agonisten auf gip-basis zur behandlung von stoffwechselerkrankungen und fettsucht | |
| EP2118300A4 (de) | Verhinderung und behandlung synukleinopathischer und amyloidogener krankheiten | |
| EP2278999C0 (de) | Ohrbehandlungsformulierungen zur behandlung von ohrenerkrankungen und -leiden | |
| DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
| EP2007393A4 (de) | Thiazol- und thiophen-analoga sowie ihre verwendung zur behandlung von autoimmunerkrankungen und karzinomen | |
| ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE516286T1 (de) | 5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes | |
| IL189528A0 (en) | Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases | |
| ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
| EP2135858A4 (de) | Zusammensetzung zur behandlung von infektionserkrankungen | |
| ATE495179T1 (de) | Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen | |
| DE602005017636D1 (de) | Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen | |
| EP2217238A4 (de) | Verfahren und zusammensetzungen zur behandlung von erkrankungen im zusammenhang mit proteinurie | |
| PL1948615T3 (pl) | Pochodne pirazolu przydatne w leczeniu chorób ginekologicznych | |
| DE602007011398D1 (de) | Trialkylsilylbenzylaminocarboxyindole, indazole und indoline und ihre verwendung zur behandlung von cetp-vermittelten erkrankungen | |
| DE502005010499D1 (de) | Implantat zur Behandlung von Fettsucht | |
| EP2164517A4 (de) | Il-18 und protein-kinase-r-hemmung zur behandlung von copd |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |